• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Pfizer Ltd.
    23 May 2025
    Tariff Relief
    5222.50
    1.39%
    FDA may change Covid-19 booster rules from 2025: What it means for you
    Business Standard
    The US Food and Drug Administration may limit Covid-19 boosters shots to high-risk groups from 2025; Pfizer reviewing proposal as agency seeks new trials, clearer risk labels for younger males
    Copy LinkShare onShare on Share on Share on
    Pfizer Ltd. is trading below its 100 day SMA of 5341.6
    logo
    Emcure Pharmaceuticals Ltd.
    23 May 2025
    1339.90
    2.73%
    Emcure Pharma hits 10% upper circuit; gains 20% in three days; here's why
    Business Standard
    Emcure Pharma hit 10 per cent upper circuit after the pharma company's Q4 net profit stood at 197.2 crore as against 121 crore, up 62 per cent
    Copy LinkShare onShare on Share on Share on
    Emcure Pharmaceuticals Ltd. has gained 27.03% in the last 6 Months
    Emcure Pharmaceuticals Shares Locked In Upper Circuit Post Q4 Profit Jump, Margin Growth
    NDTV Profit | 23 May 2025
    logo
    Indoco Remedies Ltd.
    23 May 2025
    290.60
    0.16%
    What drove Indoco Remedies share price 6% higher today? Top details inside
    Business Standard
    Indoco Remedies' share price rose after the company received final USFDA approval for its ANDA to market Allopurinol tablets USP, 200 mg - a generic version of Zyloprim 200 mg by Casper Pharma LLC.
    Copy LinkShare onShare on Share on Share on
    Indoco Remedies Ltd. has an average target of 325.00 from 2 brokers.
    logo
    Sun Pharmaceutical Industries Ltd.
    22 May 2025
    1631.20
    -0.31%
    Sun Pharma to seek commercialisation partner for one of its specialty products
    Business Line
    Recent US directives still in need of clarity, says CMD
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 1351 to 1326 in Jun 2025 qtr
    logo
    Emcure Pharmaceuticals Ltd.
    22 May 2025
    1339.90
    2.73%
    Emcure Q4 profit jumps 63%, domestic business drives 19.5% revenue rise
    Business Standard
    Emcure Pharma posted strong March quarter results with 63% rise in net profit and 19.5% growth in revenue, driven by robust domestic demand and global segment performance
    Copy LinkShare onShare on Share on Share on
    Emcure Pharmaceuticals Ltd. is trading above its 200 day SMA of 1243.0
    logo
    Lincoln Pharmaceuticals Ltd.
    22 May 2025
    532.55
    0.11%
    Lincoln Pharma posts Rs 11.62 cr profit for Jan-Mar; revenue at Rs 161 cr
    Business Standard
    Lincoln Pharmaceuticals on Thursday reported a net profit of Rs 11.62 crore for the March quarter of 2024-25 and said it is building a portfolio in lifestyle and chronic segments, particularly in women's healthcare and dermatology. The Ahmedabad-based company in a statement said that it focuses on expanding its global footprint by registering new products for export and also building a portfolio in lifestyle and chronic segments. The pharma company had reported a net profit of Rs 18.8 crore in the year-ago period. Revenue from operations rose to Rs 161.30 crore in the last quarter of FY25 from Rs 149.51 crore in the year-ago period. "The company remain committed to net debt-free and continues to leverage strategic product launches in both domestic and international markets to strengthen our market presence," Lincoln Pharmaceuticals Managing Director Mahendra Patel said. For the full fiscal, the company reported a net profit of Rs 82.44 crore against Rs 93.36 crore in FY24. Total .
    Copy LinkShare onShare on Share on Share on
    Lincoln Pharmaceuticals Ltd. is trading below all available SMAs
    logo
    Mankind Pharma Ltd.
    22 May 2025
    2448.00
    0.34%
    Mankind Pharma shares slide 3% as Q4 profit declines; details here
    Business Standard
    Shares of Mankind Pharma dropped over 3 per cent after it posted a 10 per cent fall in consolidated net profit Q4 FY25
    Copy LinkShare onShare on Share on Share on
    Mankind Pharma Ltd. has an average target of 2840.50 from 2 brokers.
    Mankind Pharma Q4: Profit drops 10%, revenue up 27% on domestic growth
    Business Standard | 21 May 2025 1 more
    Mankind Pharma Q4 Results: Profit Falls 10% But Beats Estimates
    NDTV Profit | 21 May 2025
    logo
    Sun Pharmaceutical Industries Ltd.
    22 May 2025
    1631.20
    -0.31%
    Q4 results today: ITC, Sun Pharma among 165 companies to announce earnings on Thursday
    Q4 results today: ITC, Sun Pharma among 165 companies to announce earnings on Thursday
    Economic Times
    ITC is anticipated to reveal moderate revenue growth, driven by cigarettes and agri businesses, while Sun Pharma is expected to showcase high single-digit bottom-line growth, fueled by strong domestic performance. Revenue growth for Sun Pharma is expected to be 9% year-on-year, while ITC's revenue is expected to rise 2% year-on-year. Analysts anticipate $500 million in US sales for Sun Pharma.
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical I.. has an average target of 2050.25 from 8 brokers.
    logo
    Gland Pharma Ltd.
    21 May 2025
    1951.40
    -1.52%
    Gland Pharma stock volatile after announcing Q4 results, dividend; Details
    Business Standard
    Gland Pharma shares volatile after posting Q4 results and dividend; check more details
    Copy LinkShare onShare on Share on Share on
    Gland Pharma Ltd. is trading below its 50 day SMA of 1966.5
    Gland Pharma Share Price Swings After Q4 Earnings
    NDTV Profit | 21 May 2025 1 more
    Gland Pharma Q4 Results: Profit Misses Estimates; Dividend Of Rs 18 Apiece
    NDTV Profit | 20 May 2025
    logo
    Accretion Pharmaceuticals Ltd.
    21 May 2025
    10-year low
    57.40
    -2.71%
    Accretion Pharmaceuticals shares list at 22% discount on NSE SME
    Business Standard
    Accretion Pharmaceuticals shares listed at 79 per share, reflecting a discount of 22 or 21.78 per cent over the issue price of 101 per share
    Copy LinkShare onShare on Share on Share on
    Accretion Pharmaceuticals Ltd. has lost -43.17% in the last 1 Year
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Infinity Infoway
    • Advance Agrolife
    • Sheel Biotech
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd (RA SEBI Reg No: INH000022507)